| Short-Term Omega 3 Fatty Acids Treatment for Dry Eye in Young and Middle-Aged Visual Display Terminal Users 2016 · O3FA group · Young and middle-aged visual display terminal users with dry eye symptoms | 240 mg | 360 mg | 45 days | 256 |
| Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity 2009 · fish-oil intervention group · Adults with metabolic syndrome; mean age 52.9 years; sex not specified | 120 mg | 180 mg | 26 weeks | 60 |
| Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial 2012 · n-3 LCPUFA group · Pregnant women from Adelaide whose unborn baby had a mother, father, or sibling with a history of medically diagnosed allergic disease | 800 mg | 100 mg | — | 368 |
| Effect of a Novel Omega-3 and Omega-6 Fatty Acid Supplement on Dry Eye Disease: A 3-month Randomized Controlled Trial 2022 · treatment supplement · Participants with moderate to severe dry eye disease | 300 mg | 1.2 g | 90 days | 24 |
| Prenatal Fish Oil Supplementation and Allergy: 6-Year Follow-up of a Randomized Controlled Trial 2016 · n-3 LCPUFA-rich fish oil capsules · Pregnant women with a family history of allergic disease | 800 mg | 100 mg | — | 367 |
| The effect of perinatal fish oil supplementation on neurodevelopment and growth of infants: a randomized controlled trial 2018 · fish oil supplementation group · Pregnant women aged 18–35 years | 120 mg | 180 mg | — | 75 |
| Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions 2006 · omega-3 fatty acids · White men with a history of myocardial infarction and ejection fractions below 40% | 585 mg | 225 mg | 120 days | — |
| Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study 2007 · omega-3 fatty acids · Children aged 5 to 17 years with autistic disorders accompanied by severe tantrums, aggression, or self-injurious behavior | 700 mg | 840 mg | 6 weeks | — |
| Fish oil supplementation reduces cortisol basal levels and perceived stress: a randomized, placebo-controlled trial in abstinent alcoholics 2013 · fish-oil supplementation · Adult men with alcohol dependence undergoing residential rehabilitation | 252 mg | 60 mg | 3 weeks | — |
| Effects of omega-3 polyunsaturated fatty acids on psychophysiological symptoms of post-traumatic stress disorder in accident survivors: A randomized, double-blind, placebo-controlled trial 2017 · omega-3 PUFAs · Japanese accident survivors who began supplementation within 10 days of accidental injury | 1.47 g | 147 mg | 12 weeks | — |
| Effects of fish oil and curcumin supplementation on cerebrovascular function in older adults: A randomized controlled trial 2020 · fish oil · Sedentary overweight/obese adults aged 50–80 years | 2 g | 400 mg | 16 weeks | — |
| Effects of fish oil and curcumin supplementation on cerebrovascular function in older adults: A randomized controlled trial 2020 · combination of fish oil and curcumin · Sedentary overweight/obese adults aged 50–80 years | 2 g | 400 mg | 16 weeks | — |
| Omega-3 polyunsaturated fatty acids supplementation improves memory in first-diagnosed, drug-naïve patients with depression: Secondary analysis of data from a randomized controlled trial 2024 · n-3 PUFAs supplementation · Outpatients with first-diagnosed, drug-naïve depression receiving venlafaxine; age and sex not reported | 960 mg | 1.44 g | 12 weeks | — |
| Effects of dietary supplementation with a combination of fish oil, bilberry extract, and lutein on subjective symptoms of asthenopia in humans 2011 · Active group · People with subjective symptoms of asthenopia; age and sex not reported | 783 mg | 162 mg | 4 weeks | 11 |
| Effects of a Long Chain n-3 Polyunsaturated Fatty Acid-rich Multi-ingredient Nutrition Supplement on Body Composition and Physical Function in Older Adults with Low Skeletal Muscle Mass 2022 · supplement (SUPP) · Community-dwelling older adults with low skeletal muscle mass; mean age 74.9 years; 18 men and 19 women in the study overall | 1.5 g | 1.5 g | 26 weeks | — |
| Fish oil amplifies the effect of propranolol in mild essential hypertension 1990 · Third subgroup: propranolol plus fish oil · Men with mild essential hypertension | 1.1 g | 1.8 g | 12 weeks | 16 |
| The effects of supplemental fish oil on blood pressure and morning cortisol in normotensive adults: a pilot study 2012 · Fish Oil (FO) · Adults, mean age 35±13 years, normotensive | 800 mg | 1.6 g | 6 weeks | — |
| Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial 2014 · eicosapentaenoic acid-docosahexaenoic acid group · Patients aged 60–80 years with a history of myocardial infarction; 81% were men. | 159 mg | 239 mg | 1200 days | — |
| Prevention of Potential Adverse Metabolic Effects of a Supplementation with Omega-3 Fatty Acids Using a Genetic Score Approach 2020 · n-3 PUFA supplementation · Adults; age, sex, and health condition not specified | 1.1 g | — | 6 weeks | 210 |
| Effects of low-dose omega-3 fatty acid substitution in type-2 diabetes mellitus with special reference to oxidative stress--a prospective preliminary study 2002 · group 2 (Maxigard group) · Adults with type 2 diabetes and BMI <27 kg/m²; age and sex not specified | 240 mg | 360 mg | 6 weeks | 25 |
| Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients 2014 · omega-3 group · Adults undergoing maintenance hemodialysis | 720 mg | 1.08 g | 120 days | 25 |
| [Metabolic syndrome reversion by polyunsaturated fatty acids ingestion] 2013 · n-3 group · Adults with metabolic syndrome | 720 mg | 1.08 g | 6 weeks | 15 |
| Supplementation with dietary ω-3 mitigates immobilization-induced reductions in skeletal muscle mitochondrial respiration in young women 2019 · ω-3 supplementation · Healthy young women, age 22 ± 3 years | 2 g | 3 g | 6 weeks | 11 |
| The influence of low intake of n-3 fatty acids on platelets in elderly people 1999 · n-3 PUFA group · healthy elderly people; age range and sex not stated | 150 mg | 30 mg | 6 weeks | 10 |
| Effect of omega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer 1992 · fish oil group · Patients with sporadic adenomatous colorectal polyps; age and sex not reported | 3.6 g | 4.1 g | 12 weeks | 10 |
| Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects 1994 · fish oil · Subjects without cystic fibrosis; mean age 13.4 years | 2.2 g | 3.2 g | 6 weeks | 8 |
| Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects 1994 · fish oil · Patients with cystic fibrosis and pancreatic insufficiency; mean age 12.2 years | 2.2 g | 3.2 g | 6 weeks | 7 |
| Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women 2008 · fish oil (FO) · pregnant women; age and health condition not specified | 500 mg | 150 mg | — | — |
| [Effect on the lipid profile of diet supplemented with fish oil concentrate] 1990 · n-3 treated group · male and female patients with cholesterol values higher than 7.0 mmol/l | 1.5 g | 2.1 g | 12 weeks | — |
| Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial 2014 · eicosapentaenoic acid-docosahexaenoic acid plus α-linolenic acid group · Patients aged 60–80 years with a history of myocardial infarction; 81% were men. | 159 mg | 239 mg | 1200 days | — |
| Effect of diets rich in either saturated fat or n-6 polyunsaturated fatty acids and supplemented with long-chain n-3 polyunsaturated fatty acids on plasma lipoprotein profiles 2017 · SFA-rich diet · Healthy subjects; age and sex not reported | 2 g | 400 mg | 6 weeks | — |
| Effect of diets rich in either saturated fat or n-6 polyunsaturated fatty acids and supplemented with long-chain n-3 polyunsaturated fatty acids on plasma lipoprotein profiles 2017 · n-6PUFA-rich diet · Healthy subjects; age and sex not reported | 2 g | 400 mg | 6 weeks | — |
| Effects of fish oil on plasma fibrinolysis in patients with mild rheumatoid arthritis 1995 · fish oil treatment group · Patients with mild rheumatoid arthritis; age and sex not reported | 1.1 g | 1.7 g | 26 weeks | — |
| The immunomodulatory effects of fish-oil supplementation in elite paddlers: A pilot randomized double blind placebo-controlled trial 2015 · fish-oil capsules · male elite paddlers undertaking an increasing exercise program | 1.2 g | 2.4 g | 4 weeks | 11 |
| Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye 2011 · omega-3 group · Patients with dry eye; age and sex not reported | 300 mg | 450 mg | 90 days | — |
| Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women 2008 · fish oil (FO) and methyl-tetra-hydrofolic acid · pregnant women; age and health condition not specified | 500 mg | 150 mg | — | — |